Time course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson’s disease

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Bioquímica e Bioloxía Moleculares_ES
dc.contributor.authorSánchez Iglesias, Sofía
dc.contributor.authorRey, Pablo
dc.contributor.authorMéndez Álvarez, Estefanía
dc.contributor.authorLabandeira García, José Luis
dc.contributor.authorSoto-Otero, Ramón
dc.date.accessioned2024-02-07T09:18:01Z
dc.date.available2024-02-07T09:18:01Z
dc.date.issued2007
dc.descriptionThis version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s11064-006-9232-6es_ES
dc.description.abstractThe unilateral and intrastriatal injection of 6-hydroxydopamine is commonly used to provide a partial lesion model of Parkinson’s disease in the investigation of the molecular mechanisms involved in its pathogenesis and to assess new neuroprotective treatments. Its capacity to induce neurodegeneration has been related to its ability to undergo autoxidation in the presence of oxygen and consequently to generate oxidative stress. The aim of the present study was to investigate the time course of brain oxidative damage induced by 6-hydroxydopamine (6 μg in 5 μl of sterile saline containing 0.2% ascorbic acid) injection in the right striatum of the rat. The results of this study show that the indices of both lipid peroxidation (TBARS) and protein oxidation (carbonyl and free thiol contents) increase simultaneously in the ipsilateral striatum and ventral midbrain, reaching a peak value at 48-h post-injection for both TBARS and protein carbonyl content, and at 24 h for protein free thiol content. A lower but significant increase was also observed in the contralateral side (striatum and ventral midbrain). The indices of oxidative stress returned to values close to those found in controls at 7-day post-injection. These data show that the oxidative stress is a possible triggering factor for the neurodegenerative process and the retrograde neurodegeneration observed after 1-week post-injection is a consequence of the cell damage caused during the first days post-injection. The optimal time to assess brain indices of oxidative stress in this model is 48-h post-injection.es_ES
dc.description.peerreviewedSIes_ES
dc.description.sponsorshipThis study was supported by Grant BFI2003-00493 from the Ministerio de Ciencia y Tecnología with the contribution of the European Regional Development Found (Madrid, Spain) and Grant PGDIT03PXIB20804PR from the Xunta de Galicia (Santiago de Compostela, Spain).es_ES
dc.identifier.citationSánchez-Iglesias, S., Rey, P., Méndez-Álvarez, E. et al. Time-Course of Brain Oxidative Damage Caused by Intrastriatal Administration of 6-Hydroxydopamine in a Rat Model of Parkinson’s Disease. Neurochem Res 32, 99–105 (2007)es_ES
dc.identifier.doi10.1007/s11064-006-9232-6
dc.identifier.urihttp://hdl.handle.net/10347/32491
dc.language.isoenges_ES
dc.publisherSpringeres_ES
dc.relation.publisherversionhttps://doi.org/10.1007/s11064-006-9232-6es_ES
dc.rights.accessRightsopen accesses_ES
dc.titleTime course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson’s diseasees_ES
dc.typejournal articlees_ES
dc.type.hasVersionAMes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication18abbdb4-47ec-4e3d-9250-d47d15f8c7bd
relation.isAuthorOfPublication28cad1ca-1880-4276-a1a5-8663e489f356
relation.isAuthorOfPublication67b68d37-7da0-4c06-971a-206d1e4b89be
relation.isAuthorOfPublication07aa8768-f929-4a05-91e0-8cb71646c458
relation.isAuthorOfPublication.latestForDiscovery18abbdb4-47ec-4e3d-9250-d47d15f8c7bd

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2007 Sánchez-Iglesias et al. (accepted).pdf
Size:
275.15 KB
Format:
Adobe Portable Document Format
Description:
Versión aceptada